Previous studies, as well as our own preliminary findings (data not shown), demonstrate that pharmacological inhibition of SPHK1 in HGSC cell lines induces cell death in vitro and reduces tumor growth in vivo [35]. The gene discussed is SPHK1; the disease is neoplasm.